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OBJECTIVEdTo characterize middle-school students from the HEALTHY study with glyce-
mic abnormalities, specifically high-risk hemoglobin A1c (A1C) (hrA1C; A1C = 5.7–6.4%) and
impaired fasting glucose (IFG; fasting plasma glucose [FPG] = 100–125 mg/dL).
RESEARCH DESIGN AND METHODSdHistory was collected by self-report, physical
measurement was collected by trained study staff, and fasting blood was drawn by trained
phlebotomists and analyzed centrally.
RESULTSdAt baseline, among 3,980 sixth graders, 128 (3.2%) had hrA1C and 635 (16.0%)
had IFG. Compared with A1C ,5.7%, hrA1C was associated with non-Hispanic black race/
ethnicity, family history of diabetes, and higher measurements of BMI, waist circumference, and
fasting insulin. Compared with FPG ,100 mg/dL, IFG was associated with Hispanic ethnicity;
increased BMI, waist circumference, and fasting insulin; higher frequency of high blood pressure;
and higher mean triglycerides. Two years later, children with hrA1C persisted as hrA1C in
59.4%, and one child (0.8%) developed A1C $6.5%; children with IFG persisted with IFG in
46.9%, and seven children (1.1%) developed FPG $126 mg/dL. Those with hrA1C compared
with IFG had a higher BMI in sixth grade, which persisted to eighth grade.
CONCLUSIONSdIn the HEALTHY study cohort, hrA1C and IFG define different groups of
youth with differentially increased diabetes risk markers. IFG is approximately fivefold more
common, but hrA1C is more persistent over time. Optimal screening strategies for diabetes in
youth remain unresolved.
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TheHEALTHY studywas conducted todetermine if a middle-school–basedintervention program could reduce
risk factors for type 2 diabetes in a multi-
ethnic cohort of students (1,2). The pri-
mary outcome for the study was a change
in the percent of students with a BMI
$85th percentile (combined prevalence
of overweight and obesity adjusted for sex
and age), which decreased by;4% in both
intervention and control schools (P = NS)
from sixth to eighth grades; however,
among the sample of students who were
overweight or obese ($85th percentile) in
sixth grade (50% of the sample), interven-
tion schools showed greater reductions in
the prevalence of obesity (BMI$95th per-
centile) than control schools, suggesting
that the intervention had an effect on obe-
sity rather than on overweight (3).
Among other risk factors for type 2
diabetes, hemoglobin A1c (A1C) and
fasting plasma glucose (FPG) were col-
lected at baseline and the end of study.
It has been suggested that A1C can iden-
tify adults with diabetes and prediabetes
(4,5). There are few prospective data re-
garding glycemic risk markers in diverse
populations of youth. HEALTHY data
were used to determine the distribution,
durability, and association of high-risk
A1C (hrA1C) with other diabetes risk fac-
tors in comparison with impaired fasting
glucose (IFG) to inform decision making
regarding screening and prevention strat-
egies in youth.
RESEARCH DESIGN AND
METHODSdThe protocol was ap-
proved by the institutional review boards
of the sites in the HEALTHY StudyGroup,
and parents and students provided ap-
propriate signed informed consent and
assent for data collection. Full details
about the HEALTHY design and inter-
vention are available elsewhere (1). Data
were collected in a health screening held
in 42middle schools at baseline and study
end. Participating students and their fam-
ilies received instructions and a phone call
reminder to not eat or drink anything but
water after midnight before the scheduled
health screening. Students self-reported
both race and ethnicity; Hispanic, non-
Hispanic (NH) black, and NH white stu-
dents (91.5% of the cohort) are included
in this analysis. Family history (FH) of di-
abetes in first-degree blood relatives was
provided by parents. Height and weight
were measured without shoes using a sta-
diometer and Seca electronic scale. Waist
circumference was measured to the near-
est 0.1 cm using a Gulick tape on bare
skin just above the iliac crest, this mea-
surement was repeated until two values
were #1 cm apart, and the average of
these two measurements was used. Fast-
ing blood samples were processed in the
field and sent to a central facility (North-
west Lipid Metabolism and Diabetes Re-
search Laboratories, University of
Washington, Seattle, WA) for analysis.
A1C = 5.7–6.4% and FPG = 100–125
mg/dL were defined as high risk for dia-
betes (5).
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Analyses were performed on the co-
hort of students with fasting glucose and
A1C values at both baseline (start of sixth
grade) and the end of the study (end of
eighth grade). Four studentswere excluded
based on baseline values suggestive of di-
abetes (three with FPG $126 mg/dL and
one with A1C $6.5%), leaving a sample
size of 3,980. Descriptive statistics are pre-
sented as mean (SD) or percent. General
linear mixed models were used to analyze
the differences between intervention and
control schools (6,7), with the covariance
structure appropriately adjusting for vari-
ability both between cluster (school) and
within cluster (students within the same
school) (8,9). Comparisons between inter-
vention versus control schools were not
significant for either A1C (P = 0.9066) or
IFG (P = 0.6980); therefore, data are pre-
sented without regard to treatment group.
P values ,0.05 are considered statistically
significant without adjustment for multiple
comparisons.
Table 1dClinical and metabolic characteristics of sixth-grade subjects (baseline) by normal and at-risk categories
A1C FPG
,5.7 (n = 3,852) 5.7–6.4 (n = 128) P value ,100 (n = 3,345) 100–125 (n = 635) P value
Age, years; mean (SD) min–max 11.3 (0.6) 10–14 11.5 (0.7) 10–14 0.0012 11.3 (0.5) 10–14 11.4 (0.6) 10–14 0.0024
Sex, %
Male 47.3 51.6 0.3320 45.5 57.2 ,0.0001
Female 52.7 48.4 54.5 42.8
Race/ethnicity, %
Hispanic 60.1 50.0 NC 57.9 69.5 0.0001
NH black 18.1 50.0 20.6 11.6
NH white 21.8 0.0 21.5 18.9
FH of diabetes, %
Yes 16.9 33.3 ,0.0001 16.8 20.6 0.0629
No 83.1 66.7 83.2 79.4
BMI, mm/kg2; mean (SD) 22.2 (5.3) 25.6 (7.3) ,0.0001 22.1 (5.3) 23.2 (5.6) ,0.0001
BMI z score; mean (SD) 0.9 (1.1) 1.4 (1.0) ,0.0001 0.9 (1.1) 1.1 (1.0) ,0.0001
BMI percentile, %
,85 50.7 36.7 0.0001 51.6 43.0 ,0.0001
85–94 19.5 17.2 19.6 18.9
$95 29.8 46.1 28.8 38.1
Waist circumference, cm; mean (SD) 75.7 (14.4) 82.9 (18.7) ,0.0001 75.4 (14.4) 78.8 (15.0) ,0.0001
Waist circumference percentile, %
,90 71.1 59.4 0.0044 71.9 64.5 0.0003
$90 28.9 40.6 28.1 35.5
Fasting insulin, mU/dL; mean (SD) 13.0 (11.2) 19.7 (18.3) ,0.0001† 12.2 (10.0) 18.6 (16.6) ,0.0001†
Fasting insulin, %
,30 93.7 82.0 ,0.0001 94.9 85.0 ,0.0001
$30 6.3 18.0 5.1 15.0
A1C, %; mean (SD) 5.12 (0.29) 5.23 (0.30) ,0.0001
A1C, %
,5.7 97.6 92.6 ,0.0001
5.7–6.4 2.4 7.4
Fasting glucose, mg/dL; mean (SD) 93.4 (6.3) 97.2 (8.3) ,0.0001
Fasting glucose, %
,100 84.7 63.3 ,0.0001
100–125 15.3 36.7
BP, %
Not high 96.7 94.5 0.1192 97.1 94.3 0.0003
High‡ 3.3 5.5 2.9 5.7
TGs, mg/dL; mean (SD) 89.4 (53.1) 90.6 (53.4) 0.4885† 88.7 (52.0) 93.3 (58.5) 0.0281†
TGs, %
,150 90.1 92.2 0.4824 90.3 89.3 0.5175
$150 9.9 7.8 9.7 10.7
HDL, mg/dL; mean (SD) 52.4 (12.2) 53.1 (13.7) 0.7335 52.6 (12.3) 51.6 (12.1) 0.2249
HDL, %
,40 13.4 13.3 0.8345 13.3 13.9 0.9736
$40 86.6 86.7 86.7 86.1
NC, model does not converge due to cell with zero frequency. †Tests performed on insulin and TGs log transformed to normal distribution. ‡High BP defined as
systolic BP $130 or diastolic BP $85.
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RESULTSdAmong the 3,980 students
in sixth grade, a small proportion (3.2%)
had hrA1C and a fivefold larger group
(16.0%) had IFG. Table 1 shows the as-
sociation of demographic and baseline
physical and metabolic characteristics
for normal and high-risk categories of
A1C and FPG. hrA1C was associated
with a higher prevalence of NH black
ethnicity/race, FH of diabetes, BMI, waist
circumference, and fasting insulin. Of
those with hrA1C, 36.7% had IFG, com-
pared with 15.3% of those with A1C
,5.7%. There was no association between
A1C and sex, high blood pressure (BP), tri-
glycerides (TGs), or HDL cholesterol.
Table 1 also shows that IFG was asso-
ciated with male sex, Hispanic ethnicity,
BMI, waist circumference, fasting insulin,
high BP, and mean TGs, but not FH of
diabetes, TGs$150 mg/dL, or HDL cho-
lesterol. Among those with IFG, only
7.4% also exhibited hrA1C in comparison
with only 2.4% among those with FPG
,100 mg/dL.
Table 2 demonstrates the relationship
of sixth-grade baseline and eighth-grade
end-of-study (EOS) results. Of the 128 stu-
dents with hrA1C at baseline, 76 (59.4%)
had hrA1C and 1 (0.8%) had A1C$6.5%
at EOS. Of the 635 with IFG in sixth grade,
298 (46.9%) had IFG in eighth grade and
7 (1.1%) had FPG $126 mg/dL. Of the
12 youth with evidence of diabetes by
A1C or FPG in eighth grade, 4 (33.3%)
had A1C $6.5% and 11 (91.7%) had
FPG $126 mg/dL; in sixth grade, among
these 12 youth, 1 (8.3%) had hrA1C and 7
(58.3%) had IFG.
Table 3 explores the baseline charac-
teristics of those with persistent (from
sixth to eighth grade) abnormalities of
A1C and FPG. The sample size becomes
small for those with hrA1C at baseline,
but in general, there are trends to greater
prevalence of baseline risk markers for di-
abetes in those with persistent elevated
A1C as compared with those that revert
to A1C,5.7% in eighth grade. The same
trends are present for IFG, where the in-
creased sample size contributes to more
statistically significant comparisons be-
tween those with persistent elevated glu-
cose compared with those who reverted
to normal in eighth grade, specifically
male sex, BMI, waist circumference, fast-
ing insulin, A1C, and prevalence of high
BP, TGs, and HDL, but not prevalence of
high-risk race/ethnicity or FH of diabetes.
Table 4 examines the baseline charac-
teristics of the four subgroups defined by
both A1C and FPG baseline values: nor-
mal for A1C (nA1C) and FPG (NFG),
hrA1C with NFG, IFG with nA1C, and
hrA1C with IFG. In general the 3,264
sixth graders with nA1C and NFG had
the least high-risk characteristics in both
sixth and eighth grades. Likewise, the 47
youth with both hrA1C and IFG had the
highest rates of FH for diabetes, indices of
obesity, waist circumference, and fasting
insulin and high BP in sixth grade, and
these differences largely persisted in
eighth grade. Sixth graders with hrA1C
but NFG (n = 81) as compared with those
with IFG but nA1C (n = 588) had similar
risk markers, although there were signif-
icantly greater abnormalities in BMI and
obesity (defined by BMI percentile $95)
but lower fasting insulin. By eighth grade,
those with hrA1C but NFG compared
with those with IFG but nA1C had statis-
tically significantly greater abnormalities
in BMI, BMI z score, obesity, waist
circumference, and fasting insulin.
Change or persistence in BMI percentile
over the study did not have a major effect
on the durability of glycemic abnormali-
ties (data not shown).
CONCLUSIONSdIn 2009, an inter-
national expert committee of the American
Diabetes Association, the International
Diabetes Federation, and the European
Association for the Study of Diabetes rec-
ommended that A1C $6.5% be used to
diagnose diabetes (4). Although prediabe-
tes was not originally discussed in this re-
port, it was subsequently suggested that
A1C values of 5.7–6.4% identified high
risk for diabetes along with IFG and im-
paired glucose tolerance (5). In the data
analyzed to establish A1C as a diagnostic
test, pediatric subjects were not well
represented.
The HEALTHY Study provides one of
the largest population-based datasets of
nondiabetic children with A1C measures.
In the sixth-grade cohort, hrA1C was a
relatively uncommon finding (3.2%)
compared with IFG (16.0%). In the sixth
grade, compared with those with A1C
,5.7%, hrA1C was associated with
known risk factors for diabetes, including
NH black race/ethnicity, FH of diabetes,
BMI, waist circumference, and fasting in-
sulin, as well as a more than twofold in-
creased risk of having IFG. hrA1Cwas not
associated with sex or traditional cardio-
vascular disease risk factors (BP, HDL,
and TGs). In contrast, IFG was associated
with male sex, Hispanic ethnicity, indices
of obesity, waist circumference, fasting in-
sulin, high BP, and mean TGs, but not FH
of diabetes, high TGs, or HDL cholesterol.
Although there were fewer students with
hrA1C compared with those with IFG,
they had an elevated high-risk profile
with regard to FH, BMI, and waist cir-
cumference. Finally, hrA1C was relatively
more likely to persist from sixth to eighth
grade than IFG. There were very few chil-
dren who developed FPG or A1C consis-
tent with the diagnosis of diabetes in
HEALTHY; more were identified in eighth
grade by FPG than by A1C, andmore often
they had IFG rather than hrA1C in sixth
grade.
There has been great controversy
about the utility of the A1C test versus
glucose measurements for screening and
diagnosis of diabetes (10). One issue often
raised is that there may be higher A1C at a
given level of glycemia in people of Afri-
can descent. However, there is contro-
versy regarding the significance of these




Eighth grade ,5.7 (n = 3,852) 5.7–6.4 (n = 128) ,100 (n = 3,345) 100–125 (n = 635)
A1C, n (%)
,5.7 mg/dL 3,761 (97.6) 51 (39.8) 3,231 (96.6) 581 (91.5)
5.7–6.4 mg/dL 88 (2.3) 76 (59.4) 112 (3.3) 52 (8.2)
$6.5 mg/dL 3 (0.1) 1 (0.8)* 2 (0.1) 2 (0.3)†
FPG, n (%)
,100 mg/dL 3,031 (78.7) 73 (57.0) 2,774 (82.9) 330 (52.0)
100–125 mg/dL 811 (21.0) 54 (42.2) 567 (17.0) 298 (46.9)
$126 mg/dL 10 (0.3) 1 (0.8)* 4 (0.1) 7 (1.1)†
*This is the same child. †The two youth with eighth-grade A1C $6.5% are among the seven with eighth-
grade FPG $126 mg/dL.
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Table 3dDemographics and metabolic characteristics of eighth-grade subjects in the sample “at risk” at baseline divided into eighth-grade
category “normal” or “not normal”
Eighth grade
Baseline category→ hrA1C (5.7–6.4) at baseline (n = 128) High-risk FPG (100–125) at baseline (n = 635)
EOS category→ A1C ,5.7 (n = 51) A1C $5.7 (n = 77) P value FPG ,100 (n = 330) FPG $100 (n = 305) P value
Age at baseline, years;
mean (SD) min–max 11.4 (0.8) 10–14 11.5 (0.6) 11–14 0.4566 11.3 (0.6) 10–14 11.4 (0.6) 10–14 0.3902
Sex, %
Male 41.2 58.4 0.0590 47.3 67.9 ,0.0001
Female 58.8 41.6 52.7 32.1
Race/ethnicity, %
Hispanic 58.8 44.2 0.7540 70.0 68.9 0.8667
NH black 41.2 55.8 11.5 11.8
NH white 0.0 0.0 18.5 19.3
FH of diabetes, %
Yes 29.4 64.4 0.3739 18.0 23.1 0.1684
No 70.6 35.6 82.0 76.9
BMI, mm/kg2; mean (SD) 27.0 (6.9) 28.3 (8.6) 0.3950 23.6 (5.3) 25.9 (6.7) ,0.0001
BMI z score; mean (SD) 1.4 (0.9) 1.4 (1.0) 0.8347 0.8 (1.0) 1.2 (1.0) ,0.0001
BMI percentile, %
,85 37.2 40.3 0.8043 57.6 43.6 ,0.0001
85–94 21.6 10.4 18.8 15.7
$95 41.2 49.3 23.6 40.7
Waist circumference, cm;
mean (SD) 86.6 (16.5) 89.4 (21.3) 0.3402 80.0 (13.4) 86.4 (17.0) ,0.0001
Waist circumference
percentile, %
,90 64.7 61.0 0.6759 81.5 65.9 ,0.0001
$90 35.3 39.0 18.5 34.1
Fasting insulin, mU/dL;
mean (SD) 20.3 (14.6) 26.7 (21.4) 0.1046* 15.9 (11.1) 23.1 (17.6) ,0.0001*
Fasting insulin, %
,30 86.3 71.4 0.0573 91.2 80.0 ,0.0001
$30 13.7 28.6 8.8 20.0
A1C, %; mean (SD) 5.14 (0.31) 5.30 (0.42) ,0.0001
A1C, %




mean (SD) 95.7 (7.4) 100.2 (11.3) 0.0054
Fasting glucose, %




Not high 90.2 94.8 0.3282 94.2 89.5 0.0315
High† 9.8 5.2 5.8 10.5
TGs, mg/dL; mean (SD) 76.6 (41.5) 81.9 (38.6) 0.4948* 79.6 (41.5) 89.8 (42.4) 0.0002*
TGs, %
,150 98.0 92.2 0.1784 94.8 91.1 0.0710
$150 2.0 7.8 5.2 8.9
HDL, mg/dL; mean (SD) 52.2 (13.1) 51.6 (14.5) 0.7440 52.1 (11.8) 48.6 (12.4) 0.0003
HDL, %
,40 17.6 18.2 0.9300 13.6 21.6 0.0076
$40 82.4 81.8 86.4 78.4
*Tests performed on insulin and TGs log transformed to normal distribution. †High BP defined as systolic BP $130 or diastolic BP $85.
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FPG (n = 81)
At-risk
FPG (100–125)
but not A1C (n = 588)
At-risk
both A1C and
FPG (n = 47)
P value for at-risk A1C
but not FPG vs. at-risk
FPG but not A1C
Sixth grade
Age, years; mean
(SD) min–max 11.3 (0.5) 10–14 11.4 (0.7) 10–14 11.3 (0.6) 10–14 11.5 (0.7) 10–14 0.2703
Sex, %
Male 45.4 49.4 57.3 55.3 0.7936
Female 54.6 50.6 42.7 44.7
Race/ethnicity, %
Hispanic 58.3 43.2 70.1 61.7 NC
NH black 19.6 56.8 9.5 38.3
NH white 22.1 0.0 20.4 0.0
FH of diabetes, %
Yes 16.6 28.8 18.9 41.2 0.0805
No 83.4 71.2 81.1 58.8
BMI, mm/kg2; mean (SD) 22.1 (5.3) 24.9 (7.2) 22.9 (5.3) 26.9 (7.4) 0.0019
BMI z score; mean (SD) 0.9 (1.1) 1.3 (1.0) 1.0 (1.0) 1.6 (0.9) 0.0864
BMI percentile, %
,85 51.9 40.7 44.1 29.8 0.0189
85–94 19.6 18.5 19.2 14.9
$95 28.5 40.8 36.7 55.3
Waist circumference, cm;
mean (SD) 75.3 (14.3) 80.6 (18.4) 78.2 (14.5) 86.9 (18.7) 0.0980
Waist circumference
percentile, %
,90 72.1 62.9 65.4 53.2 0.6307
$90 27.9 37.1 34.6 46.8
Fasting insulin, mU/dL;
mean (SD) 12.2 (9.7) 15.9 (16.9) 18.0 (16.3) 26.2 (19.1) 0.0125†
Fasting insulin, %
,30 95.1 88.9 86.2 70.2 0.5253
$30 4.9 11.1 13.8 29.8
BP, %
Not high 97.0 98.8 94.9 87.2 0.1751
High‡ 3.0 1.2 5.1 12.8
TGs, mg/dL; mean (SD) 88.7 (52.1) 89.2 (52.0) 93.3 (58.8) 93.1 (56.2) 0.8838†
TGs, %
,150 90.3 92.6 89.1 91.5 0.3997
$150 9.7 7.4 10.9 8.5
HDL, mg/dL; mean (SD) 52.5 (12.3) 53.1 (11.7) 51.5 (11.7) 53.0 (16.7) 0.6299
HDL, %
,40 13.3 12.3 13.8 14.9 0.9049
$40 86.7 87.7 86.2 85.1
Eighth grade
BMI, mm/kg2; mean (SD) 23.8 (5.6) 27.2 (7.9) 24.4 (5.8) 28.7 (8.0) ,0.0001
BMI z score; mean (SD) 0.8 (1.0) 1.3 (1.0) 1.0 (1.0) 1.5 (0.9) 0.0044
BMI percentile, %
,85 55.5 40.7 52.0 36.2 0.0007
85–94 20.7 17.3 17.9 10.6
$95 23.8 42.0 30.1 53.2
Waist circumference,
cm; mean (SD) 80.3 (14.3) 86.8 (18.9) 82.5 (14.9) 90.8 (20.4) 0.0066
Waist circumference
percentile, %
,90 78.8 65.4 75.3 57.5 0.0536
$90 21.2 34.6 24.7 42.5
Continued on p. 434
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differences and whether they are of ge-
netic or socioeconomic origin (11). There
is an evolving consensus that, at least in
selected adult populations where the A1C
measurement is appropriate (e.g., no clin-
ical conditions associated with reduced
erythrocyte survival) and when the assay is
appropriately performed, A1C identifies
a population with diabetes that is smaller
than that defined by FPG or oral glucose
tolerance test (OGTT) but with similar or
higher risk of microvascular and macrovas-
cular complications.
Similarly, a recent study in obese
youth demonstrated that the A1C cut
point of $6.5% was relatively insensitive
for detecting diabetes compared with FPG
or OGTT; however, A1C did perform
similarly in defining youth at high risk
of diabetes with prospective follow-up
(12). A second study in youth demon-
strated lower sensitivity of A1C measure-
ments to define diabetes and especially
prediabetes as defined by FPG or OGTT
(13). This raises the issue of whether
lower A1C thresholds should be used to
define glycemic abnormalities in youth, as
has been suggested elsewhere (14). Setting
a cut point to define diabetes risk categor-
ically as low or high in screening is in-
herently controversial as there is a
continuously increasing risk for the future
development of diabetes as the level of any
glycemicmarker approaches the diagnostic
cut point. If the rationale for defining di-
abetes risk is to intervene to prevent
disease, the choice of the cut point to define
high riskmust take into account howmany
individuals would need to be treated at
what cost in order to prevent diabetes.
These issues are even more complex in
youth, as glycemic measures are in flux re-
lated to pubertal development. Further-
more, the prospective studies that would
be required to define the cardiovascular
and microvascular consequences of sub-
clinical glycemic abnormalities in youth
and the potential mitigating effect of inter-
ventions would be extremely large and
prolonged. Inherently, the evidence base
for the cut points for high risk for diabetes
in youth is even more arbitrary than in
adults.
In the HEALTHY cohort, the FPG and
A1C tests identify two different high-risk
populations. The IFG population is five
times as large and less likely to persist with
glycemic abnormalities but more hyper-
tensive and more dyslipidemic. Arguably,
these features suggest a population where
there may be a benefit of intervention and
follow-up to prevent cardiovascular risk.
The hrA1C population is a relatively small
minority of those with glycemic abnormal-
ities, but they are substantially more obese
and exhibit the other most powerful risk
factors for diabetes in youth (FH and eth-
nicity) more frequently. These features may
be more amenable for diabetes prevention
and follow-up strategies. However, only
58% of those with diabetes at the end of
the study had either hrA1C or IFG at the
beginning, and the vast majority of those
with hrA1C or IFG at the beginning of
the study did not develop diabetes over 2
years, suggesting modest screening value
of either measure. Further study is re-
quired to establish the optimal screening
and intervention strategy to reduce cardi-
ometabolic risk in youth.
AcknowledgmentsdThis work was com-
pleted with funding from the National Institute
of Diabetes and Digestive and Kidney Diseases/
National Institutes of Health grants U01-DK-
61230, U01-DK-61249, U01-DK-61231, and
U01-DK-61223, with additional support from
the American Diabetes Association.
F.R.K. has a position with Medtronic Inc.
and owns stock. No other potential conflicts of
interest relevant to this article were reported.
J.B.B. and K.H. researched data, contributed
to discussion, wrote the manuscript, and re-
viewed and edited the manuscript. F.R.K. con-
tributed to discussion, wrote the manuscript,
and reviewed and edited the manuscript. B.L.
contributed to discussion and reviewed and
edited the manuscript. L.E. researched data and
reviewed and edited the manuscript. S.W. re-
searched data, contributed to discussion, and
reviewed and edited the manuscript. K.H. and
L.E. are the guarantors of this work and, as such,
had full access to all the data in the study and
take responsibility for the integrity of the data
and the accuracy of the data analysis.
The authors thank the administration, fac-
ulty, staff, students, and their families at the
middle schools and school districts that par-







FPG (n = 81)
At-risk
FPG (100–125)
but not A1C (n = 588)
At-risk
both A1C and
FPG (n = 47)
P value for at-risk A1C
but not FPG vs. at-risk
FPG but not A1C
Fasting insulin,
mU/dL; mean (SD) 16.7 (14.2) 22.0 (17.8) 18.7 (14.3) 27.9 (20.9) 0.0368†
Fasting insulin, %
,30 90.0 81.5 87.1 70.2 0.1629
$30 10.0 18.5 12.9 29.8
BP, %
Not high 97.0 93.8 92.0 91.5 0.5597
High‡ 3.0 6.2 8.0 8.5
TGs, mg/dL; mean (SD) 82.8 (48.1) 78.7 (42.2) 84.8 (42.7) 81.7 (35.5) 0.8745†
TGs, %
,150 93.1 95.1 93.0 93.6 0.5587
$150 6.9 4.9 7.0 6.4
HDL, mg/dL; mean (SD) 51.5 (12.3) 51.9 (12.2) 50.3 (11.8) 51.7 (16.5) 0.4416
HDL, %
,40 15.6 14.8 17.0 23.4 0.8239
$40 84.4 85.2 83.0 76.6
NC, model does not converge due to cell with zero frequency. †Tests performed on insulin and TGs log transformed to normal distribution. ‡High BP defined as
systolic BP $130 or diastolic BP $85.
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Screening youth for diabetes with A1C versus FPG
intervention materials are available for down-
load at http://www.healthystudy.org/.
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